Pathophysiology of myocardial injury and remodeling: Implications for molecular imaging

Journal of Nuclear Medicine

Volumn 51, Issue SUPPL.1, 2010, Pages

  Dixon, Jennifer A ^a   Spinale, Francis G ^a  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Basic cardiology; Cardiac MRI; Clinical cardiology; Infarct expansion; MRI; Myocardial remodeling; Technical cardiology

Indexed keywords

ACTIN; COLLAGEN; INTEGRIN; MATRIX METALLOPROTEINASE; NITINOL; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

APOPTOSIS; CELL PROLIFERATION; CELL VIABILITY; HEART FAILURE; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART MUSCLE PERFUSION; HEART VENTRICLE REMODELING; HUMAN; MESH SLING; MOLECULAR IMAGING; MYOCARDIAL PERFUSION IMAGING; MYOFIBROBLAST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; ANIMAL; BIOPHYSICS; CARDIOLOGY; CYTOLOGY; DIAGNOSTIC IMAGING; HEART; HEART MUSCLE; HEART VENTRICLE; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; REPERFUSION; STEM CELL;

ANIMALS; APOPTOSIS; BIOPHYSICS; CARDIOLOGY; DIAGNOSTIC IMAGING; HEART; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIUM; PROGNOSIS; REPERFUSION; STEM CELLS; VENTRICULAR REMODELING;

EID: 77953064222     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.068213     Document Type: Review

References (39)

1. Krumholz HM, Anderson JL, Bachelder BL, et al. ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for ST-Elevation and Non-ST-Elevation Myocardial Infarction). J Am Coll Cardiol. 2008;52:2046-2099.
2. Russo CA, Andrews RM. The National Hospital Bill: The Most Expensive Conditions, by Payer, 2004. Rockville, MD: Agency for Healthcare Research and Quality; 2006. HCUP statistical brief no. 13.
3. Cleutjens JP, Kandala JC, Guarda E, Guntaka RV, Weber KT. Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol. 1995;27:1281-1292.
4. Judd JT, Wexler BC. Prolyl hydroxylase and collagen metabolism after experimental myocardial infarction. Am J Physiol. 1975;228:212-216.
5. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44-51.
6. McCormick RJ, Musch TI, Bergman BC, Thomas DP. Regional differences in LV collagen accumulation and mature cross-linking after myocardial infarction in rats. Am J Physio. 1994;266:H354-H359.
7. Jugdutt BI, Lucas A, Khan MI. Effect of angiotensin-converting enzyme inhibition on infarct collagen deposition and remodelling during healing after transmural canine myocardial infarction. Can J Cardiol. 1997;13:657-668.
8. Jugdutt BI, Joljart MJ, Khan MI. Rate of collagen deposition during healing and ventricular remodeling after myocardial infarction in rat and dog models. Circulation. 1996;94:94-101.
9. van den Borne SW, Isobe S, Verjans JW, et al. Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction. J Am Coll Cardiol. 2008;52:2017-2028.
10. Harada K, Friedman M, Lopez JJ, et al. Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol. 1996;270:H1791-H1802.
11. Voisine P, Bianchi C, Ruel M, et al. Inhibition of the cardiac angiogenic response to exogenous vascular endothelial growth factor. Surgery. 2004;136:407-415.
12. Boodhwani M, Sodha NR, Mieno S, et al. Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes. Circulation. 2007;116(11, suppl)I31-I37.
13. Meoli DF, Sadeghi MM, Krassilnikova S, et al. Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. J Clin Invest. 2004;113:1684-1691.
14. Wilson EM, Moainie SL, Baskin JM, et al. Region- and type-specific induction of matrix metalloproteinases in post-myocardial infarction remodeling. Circulation. 2003;107:2857-2863.
15. Dixon JA, Gorman RC, Stroud RE, et al. Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction. Circulation. 2009;120(11, suppl):S220-S229.
16. Ekhterae D, Hinmon R, Matsuzaki K, et al. Infarction induced myocardial apoptosis and ARC activation. J Surg Res. June 6, 2009 [Epub ahead of print].
17. Hamamoto H, Gorman JH III, Ryan LP, et al. Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage. Ann Thorac Surg. 2009;87:794-801.
18. Jugdutt BI, Menon V, Kumar D, Idikio H. Vascular remodeling during healing after myocardial infarction in the dog model: effects of reperfusion, amlodipine and enalapril. J Am Coll Cardiol. 2002;39:1538-1545.
19. Sosnovik DE, Nahrendorf M, Panizzi P, et al. Molecular MRI detects low levels of cardiomyocyte apoptosis in a transgenic model of chronic heart failure. Circ Cardiovasc Imaging. 2009;2:468-475.
20. Grothues F, Smith GC, Moon JC, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002;90:29-34.
21. Azevedo CF, Cheng S, Lima JA. Cardiac imaging to identify patients at risk for developing heart failure after myocardial infarction. Curr Heart Fail Rep. 2005;2:183-188.
22. Friedrich MG, Abdel-Aty H, Taylor A, Schulz-Menger J, Messroghli D, Dietz R. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol. 2008;51:1581-1587.
23. Weis S, Shintani S, Weber A, et al. Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. J Clin Invest. 2004;113:885-894.
24. Lima JA, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI: potential mechanisms. Circulation. 1995;92:1117-1125.
25. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the "no reflow" phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation. 1996;93:223-228.
26. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998;97:765-772.
27. Beek AM, Kühl HP, Bondarenko O, et al. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol. 2003;42:895-901.
28. Maes A, Van de Werf F, Nuyts J, Bormans G, Desmet W, Mortelmans L. Impaired myocardial tissueperfusion early after successful thrombolysis: impact onmyocardial flow, metabolism, and function at late follow-up. Circulation. 1995;92:2072-2078.
29. Gerber BL, Belge B, Legros GJ, et al. Characterization of acute and chronic myocardial infarcts by multidetector computed tomography: comparison with contrast-enhanced magnetic resonance. Circulation. 2006;113:823-833.
30. Nieman K,ShapiroMD,FerencikM, et al.Reperfusedmyocardial infarction: contrast-enhanced 64-section CT in comparison toMR imaging. Radiology. 2008;247:49-56.
31. Wu EX, Wu Y, Nicholls JM, et al. MR diffusion tensor imaging study of postinfarct myocardium structural remodeling in a porcine model. Magn Reson Med. 2007;58:687-695.
32. Wu MT, Tseng WY, Su MY, et al. Diffusion tensor magnetic resonance imaging mapping the fiber architecture remodeling in human myocardium after infarction: correlation with viability and wall motion. Circulation. 2006;114:1036-1045.
33. Hu Q, Wang X, Lee J, et al. Profound bioenergetic abnormalities in peri-infarct myocardial regions. Am J Physiol Heart Circ Physiol. 2006;291:H648-H657.
34. Feygin J,Mansoor A, Eckman P, Swingen C, Zhang J. Functional and bioenergetic modulations in the infarct border zone following autologous mesenchymal stem cell transplantation. Am J Physiol Heart Circ Physiol. 2007;293:H1772-H1780.
35. Magovern JA, Teekell-Taylor L, Mankad S, et al. Effect of a flexible ventricular restraint device on cardiac remodeling after acute myocardial infarction. ASAIO J. 2006;52:196-200.
36. Blom AS, Pilla JJ, Arkles J, et al. Ventricular restraint prevents infarct expansion and improves borderzone function after myocardial infarction: a study using magnetic resonance imaging, three-dimensional surface modeling, and myocardial tagging. Ann Thorac Surg. 2007;84:2004-2010.
37. Kim YJ, Huh YM, Choe KO, et al. In vivo magnetic resonance imaging of injected mesenchymal stem cells in rat myocardial infarction: simultaneous cell tracking and left ventricular function measurement. Int J Cardiovasc Imaging. 2009;25(suppl 1):99-109.
38. Hill JM, Dick AJ, Raman VK, et al. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation. 2003;108:1009-1014.
39. Kraitchman DL, Heldman AW, Atalar E, et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation. 2003;107:2290-2293.